INTRODUCTION {#S1}
============

The nucleus accumbens (NAc) mediates reward-related behaviors and is reorganized by repeated exposure to drugs of abuse ([@R22]; [@R33]). Throughout the striatum, medium spiny neurons (MSNs) segregate into two broad populations, expressing either the D1 or D2 subtype of dopamine receptors ([@R16]; [@R31]). Selective activation of D1+ or D2+ MSNs engage distinct patterns of brain wide activity ([@R30]) and exert opposing influences on motivated behavior ([@R4]; [@R9]; [@R13]; [@R24], [@R25]; [@R32]). In the dorsal striatum, D1+ MSNs project via the "direct" pathway to the substantia nigra, whereas D2+ MSNs project via the "indirect" pathway to the globus pallidus ([@R24]; [@R49]). Recent work highlights additional diversity of D1+ MSNs between ([@R53]) and within ([@R2]; [@R18]) different subregions of the NAc. In particular, D1+ MSNs can project to multiple targets ([@R18]; [@R39]; [@R40]), including the ventral pallidum (VP) and ventral tegmental area (VTA) ([@R13]; [@R27]). However, it remains unclear whether distinct subpopulations of D1+ MSNs project to the VP and VTA and if these cells receive and process different synaptic connections.

MSNs in the NAc medial shell (NAcMS) are driven by long-range excitatory inputs, including from the ventral hippocampus (vHPC) and basolateral amygdala (BLA) ([@R7]; [@R43]; [@R47]). These inputs carry distinct motivational signals ([@R3]; [@R8]; [@R19]; [@R50]) and undergo robust drug-evoked synaptic plasticity ([@R7]; [@R36]; [@R42]). Changes in synaptic strength contribute to the development of addiction ([@R6]; [@R34]) and depend on both the presynaptic input (vHPC versus BLA) and postsynaptic cell type (D1+ versus D2+). For example, cocaine exposure primarily rewires connections to D1+ MSNs ([@R21]; [@R23]; [@R28]; [@R36]; [@R42]), but the mechanisms differ for BLA and vHPC inputs ([@R7]; [@R36]; [@R42]). However, it is unknown if changes in synaptic strength are homogeneous across D1+ MSNs or also depend on their projection targets (VP versus VTA). For example, does equivalent plasticity occur for all D1+ MSNs, or are particular output pathways strengthened or weakened? Similarly, does the same plasticity occur for vHPC and BLA inputs, or are signals differentially routed to downstream areas? Here we answer these questions in the mouse NAcMS, revealing a critical role for the projection target of MSNs.

RESULTS {#S2}
=======

Distinct Subpopulations of D1+ MSNs Project to the VP and VTA {#S3}
-------------------------------------------------------------

To examine the projection targets of MSNs, we first injected anterograde AAV-eGFP into the NAcMS, which labeled axons in both the VP and VTA ([Figure S1](#SD1){ref-type="supplementary-material"}). To identify projection neurons in the NAcMS, we then injected fluorescent retrograde tracers (cholera toxin subunit B \[CTB\]-647 and CTB-488) into the VP and VTA of D1-tdTomato mice. We found that VTA projections consist largely of D1+ MSNs, while the VP receives inputs from both D1+ and D1− MSNs, with the latter used as a proxy for D2+ MSNs ([Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}) ([@R46]). Overall, retrograde injections in the VP and the VTA labeled equivalent numbers of D1+ MSNs (VP = 225 ± 32 cells per mouse; VTA =170 ± 30 cells per mouse; Mann-Whitney test: U = 7, p = 0.3; n = 5 mice). However, there was minimal co-labeling (dual-labeled cells = 32 ± 6 cells per mouse, 7% of labeled D1+ MSNs; n = 5 mice), indicating that D1+ MSNs targeting the VP (D1+^VP^) or targeting the VTA (D1+^VTA^) are largely distinct populations ([Figure 1B](#F1){ref-type="fig"}). We next examined if D1+^VP^ and D1+^VTA^ MSNs could be differentiated on the basis of their morphological or physiological properties. Using whole-cell recordings and two-photon microscopy, we found subtle differences between D1+ and D1− MSNs ([@R17]; [@R26]; [@R48]), but none between D1+^VP^ and D1+^VTA^ MSNs. All MSN subtypes had similar dendritic lengths (D1− = 1,213 ± 108 μm; D1+^VTA^ = 1,289 ± 114 μm; D1+^VP^ = 1,404 ± 138 μm; Kruskal-Wallis test: H\[2\] = 1.184, p = 0.6; n = 12--14 cells from 8--10 mice per group) ([Figure 1C](#F1){ref-type="fig"}) and intrinsic properties ([Figure S1](#SD1){ref-type="supplementary-material"}), but D1− MSNs were more excitable than both D1+^VP^ and D1+^VTA^ MSNs (two-way ANOVA: current step × cell type interaction, F\[16, 296\] = 6.6, p \< 0.0001; Sidak's multiple comparisons: p = 0.4; n = 12--14 cells from 8--10 mice per group) ([Figure 1D](#F1){ref-type="fig"}). These results reveal two subpopulations of D1+ MSNs in the NAcMS, motivating us to ask how they are contacted by afferents and whether these connections undergo differential synaptic plasticity.

Hippocampal Inputs Are Selectively Biased onto D1+^VTA^ MSNs {#S4}
------------------------------------------------------------

We next examined how long-range afferents from the vHPC and the BLA contact D1+^VTA^ and D1+^VP^ MSNs in the NAcMS. These inputs differentially target D1+ and D1− MSNs and undergo distinct forms of drug-evoked synaptic plasticity ([@R36]). To study specific connections, we injected AAV-ChR2-eYFP in the vHPC or the BLA and CTB-647 in the VTA or the VP of D1-tdTomato mice. vHPC fibers in the NAc were largely restricted to the NAcMS ([Figure 2A](#F2){ref-type="fig"}; n = 3 mice) ([@R7]), where they preferentially synapsed onto D1+ MSNs ([Figure S2](#SD1){ref-type="supplementary-material"}; n = 9 pairs / 5 mice) ([@R35], [@R36]; [@R46]). To determine if this connectivity depends on projection target, we recorded AMPAR and NMDAR excitatory postsynaptic currents (EPSCs) from pairs of nearby D1+^VTA^ and D1− MSNs or D1+^VP^ and D1− MSNs in the same slice, allowing us to directly compare synaptic strength ([@R35], [@R36]; [@R46]). We found that vHPC-evoked AMPAR EPSCs were larger onto D1+^VTA^ MSNs relative to neighboring D1− MSNs (AMPAR amplitude: D1− = 245 ± 47 pA, D1+^VTA^ = 493 ± 44 pA; Wilcoxon test: W = 55, p = 0.002) ([Figure 2B](#F2){ref-type="fig"}), with a similar bias found for vHPC-evoked NMDAR EPSCs ([Figure S1](#SD1){ref-type="supplementary-material"}). We quantified this bias as the EPSC amplitude ratio for each pair of recorded neurons (D1+^VTA^ / D1− ratio: AMPAR = 2.2 \[95% CI = 1.5--3.3\]; one-sample t test: t(9) = 4.9, p = 0.0009; NMDAR = 1.9 \[95% CI = 1.1--3.1\]; one-sample t test: t(9) = 2.8, p = 0.02; n = 10 pairs/7 mice) ([Figures 2B](#F2){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). Surprisingly, this bias was absent when comparing vHPC-evoked EPSCs at pairs of D1+^VP^ and D1− MSNs (AMPAR amplitude: D1− = 462 ± 79 pA, D1+^VP^ = 398 ± 42 pA; Wilcoxon test: W = −13, p = 0.5) (D1+^VP^ / D1− ratio: AMPAR = 0.9 \[95% CI = 0.7--1.2\]; one-sample t test: t(8) = 0.7, p = 0.5; NMDAR = 0.8 \[95% CI = 0.6--1.2\]; one-sample t test: t(8) = 1.1, p = 0.3; n = 9 pairs / 8 mice) ([Figure 2C](#F2){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). These findings indicate that preferential targeting of vHPC inputs onto D1+ MSNs is not a universal property but a specific feature of cells that project to the VTA.

BLA fibers are also prominent in the NAcMS ([Figure 2D](#F2){ref-type="fig"}; n = 3 mice) but, unlike vHPC inputs, are unbiased onto D1+ and D1− MSNs ([Figure S2](#SD1){ref-type="supplementary-material"}; n = 7 pairs/5 mice) ([@R36]). We found that BLA-evoked AMPAR and NMDAR EPSCs were also unbiased at neighboring D1+^VTA^and D1− MSNs (AMPAR amplitude: D1− = 247 ± 76 pA, D1+^VTA^ = 221 ± 63 pA; Wilcoxon test: W = −8, p = 0.6) (D1+^VTA^ / D1− ratio: AMPAR = 0.9 \[95% CI = 0.4--2.0\]; one-sample t test: t(7) = 0.4, p = 0.7; NMDAR = 1.1 \[95% CI = 0.6--2.0\]; one-sample t test: t(7) = 0.3, p = 0.8; n = 8 pairs / 6 mice) ([Figures 2E](#F2){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}) and pairs of D1+^VP^ and D1− MSNs (AMPAR amplitude: D1− = 242 ± 62 pA, D1+^VP^ = 214 ± 42 pA; Wilcoxon test: W = 0, p \> 0.9) (D1+^VP^ / D1− ratio: AMPAR =1.0 \[95% CI = 0.6--1.6\]; one-sample t test: t(6) = 0.009, p = 1.0; NMDAR = 1.0 \[95% CI = 0.6--1.7\]; one-sample t test: t(6) = 0.1, p = 0.9; n = 7 pairs / 6 mice) ([Figures 2F](#F2){ref-type="fig"} and [S1](#SD1){ref-type="supplementary-material"}). Because similar targeting was found for AMPAR and NMDAR EPSCs, there was no difference in the AMPAR/NMDAR ratio across input or cell type ([Figure S1](#SD1){ref-type="supplementary-material"}). Together, these results suggest that baseline connectivity strongly depends on both the specific input and output of D1+ MSNs.

Cocaine-Evoked Synaptic Plasticity Depends on MSN Projection Target {#S5}
-------------------------------------------------------------------

Cocaine exposure fundamentally rewires circuits in the NAcMS, and these effects occur predominantly at D1+ MSNs ([@R36]; [@R42]; [@R46]). However, it remains unknown if drug-evoked synaptic plasticity depends primarily on dopamine receptor expression or projection target. For example, does plasticity occur at all D1+ MSNs, irrespective of downstream target? Or does it occur at only a subset of D1+ MSNs that project to either the VP or VTA? To distinguish between these possibilities, we next examined the impact of cocaine sensitization on synaptic connectivity at the three subtypes of MSNs. Mice were injected with either cocaine or saline for 5 consecutive days, followed by a cocaine challenge after a 24 h withdrawal ([Figure 3A](#F3){ref-type="fig"}). Cocaine-treated mice showed increased locomotion in response to the cocaine challenge, a signature of sensitization (distance traveled: cocaine, 15.3 ± 1.8 m; saline, 8.1 ± 0.7 m; Mann-Whitney test: U = 34, p = 0.03; n = 12 mice per group) ([Figure 3B](#F3){ref-type="fig"}).

To examine cocaine-evoked synaptic plasticity, we used the same protocol but performed acute slice recordings on the challenge day instead of behavior ([Figure 3A](#F3){ref-type="fig"}). We found that cocaine exposure equalized vHPC inputs onto D1+^VTA^ and nearby D1− cells, whereas saline exposure had no effect (D1+^VTA^/ D1− ratio: AMPAR: cocaine = 1.0 \[95% CI = 0.7--1.4\]; saline = 2.4 \[95% CI = 1.3--4.5\]; Mann-Whitney test: U = 9, p = 0.01; NMDAR: cocaine = 0.8 \[95% CI = 0.5--1.2\]; saline = 2.6 \[95% CI, 1.2--5.4\]; Mann-Whitney test: U = 6, p = 0.005; n = 8 pairs from 5 or 6 mice per group) ([Figures 3C](#F3){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}). In contrast, vHPC inputs remained similar onto nearby D1+^VP^ and D1− cells in both cocaine- and saline-treated mice (D1+^VP^ / D1− ratio: AMPAR: cocaine = 1.2 \[95% CI = 0.7--1.9\]; saline = 1.0 \[95% CI = 0.61.5\]; Mann-Whitney test: U = 32, p = 0.7; NMDAR: cocaine = 1.5 \[95% CI = 0.8--2.6\]; saline = 1.0 \[95% CI = 0.6--1.5\]; Mann-Whitney test: U = 20, p = 0.1; n = 8 or 9 pairs from 7 or 9 mice per group) ([Figures 3D](#F3){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}). These results agree with previous work showing that cocaine dampens vHPC inputs onto unsorted D1+ MSNs ([Figure S4](#SD1){ref-type="supplementary-material"}; n = 8 or 9 pairs from 5 or 6 mice per group) ([@R36]; [@R46]). However, they further indicate that drug-evoked plasticity of vHPC inputs is highly selective for D1+ MSNs projecting to the VTA.

Last, we performed parallel experiments for BLA inputs. Surprisingly, we found that cocaine exposure did not potentiate BLA inputs onto D1+^VTA^ MSNs, resulting in similar targeting to saline-treated mice (D1+^VTA^/ D1− ratio: AMPAR: cocaine = 0.8 \[95% CI = 0.4--1.7\]; saline = 1.0 \[95% CI = 0.5--2.0\]; Mann-Whitney test: U = 33, p = 0.5; NMDAR: cocaine = 0.8 \[95% CI = 0.61.1\]; saline = 0.8 \[95% CI = 0.4--1.7\]; Mann-Whitney test: U = 40, p \>0.99; n = 9 pairs/6 or 7 mice per group) ([Figures 3E](#F3){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}). In contrast, cocaine greatly enhanced BLA inputs onto D1+^VP^ MSNs relative to D1− MSNs, whereas saline exposure had no effect (D1+^VP^ / D1− ratio: AMPAR: cocaine = 3.9 \[95% CI = 2.0--7.8\]; saline = 1.1 \[95% CI = 0.7--2.0\]; Mann-Whitney test: U = 15, p = 0.01; NMDAR: cocaine = 2.8 \[95% CI = 1.2--6.3\]; saline = 0.9 \[95% CI = 0.5--1.4\]; Mann-Whitney test: U = 13, p = 0.008; n = 10 pairs from 7 or 10 mice per group) ([Figures 3F](#F3){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}). These findings are consistent with cocaine's enhancing BLA inputs onto unsorted D1+ cells ([Figure S4](#SD1){ref-type="supplementary-material"}; n = 12 or 13 pairs from 9 mice per group) ([@R36]). However, they highlight the importance of projection target, showing that drug-evoked plasticity of BLA inputs occurs only at D1+ MSNs projecting to the VP.

DISCUSSION {#S6}
==========

Our results indicate that synaptic connectivity and cocaine-evoked plasticity depend on the specific afferent, type of dopamine receptor, and projection target of MSNs. We found that D1+ MSNs in the NAcMS consist of two distinct populations that send projections to either the VP or the VTA. Although both subtypes are contacted by inputs from the vHPC and the BLA, vHPC inputs are stronger onto D1+^VTA^ MSNs, whereas BLA inputs show no bias. Cocaine exposure selectively dampens vHPC inputs at D1+^VTA^ MSNs but strengthens BLA inputs at D1+^VP^ MSNs. These findings emphasize the importance of the projection targets of D1+ MSNs and how drug exposure reshapes the NAc circuit in both an input- and output-specific manner.

Recent evidence highlights how diverse projections of the NAc participate in motivated behavior ([@R13]; [@R18]; [@R40]; [@R41]). However, it has been unclear if these projections consisted of collateralizing axon or discrete populations of neurons. We used dual retrograde labeling to show that both D1+ and D1− MSNs project to the VP, whereas only D1+ MSNs project to the VTA. Moreover, we found that D1+ MSNs projecting to the VP and VTA are two largely separate populations of neurons in the NAcMS. This finding contrasts with a recent report, which concluded that the majority of D1+ MSNs in the NAcMS and NAc core collateralize to both the VP and VTA ([@R41]). The reason for this discrepancy is unclear but could reflect differences in injection strategies. We targeted the VP at an angle in order to avoid the anterior commissure and potential leak into the NAc itself. Our anatomical findings are consistent with the highly selective synaptic connectivity and drug-evoked plasticity we observed at these two classes of projection neurons. Because D1+ MSNs that project to the VTA and LH also represent different subpopulations of cells ([@R18]), our results establish that D1+ MSNs constitute multiple parallel output pathways with distinct connectivity, plasticity, and behavioral implications.

Our findings build on decades of work on drug-evoked plasticity in the NAc ([@R6]; [@R31]; [@R33]; [@R34]), revealing unexpected complexities in how neural circuits can be modified in the progression to addiction ([@R20]; [@R33]). Early work showed that cocaine exposure dramatically alters dendrite and spine morphology ([@R14]; [@R38]; [@R44]), which suggested that synaptic connections might be fundamentally reorganized. Cocaine-evoked synaptic plasticity is now well established, with changes in glutamatergic signaling in the NAc closely linked to behavior ([@R4]; [@R12]; [@R42]; [@R45]). Recently, this reorganization was shown to depend on both input and cell type ([@R7]; [@R36]; [@R42]). For example, drug-evoked plasticity throughout the NAc primarily occurs at D1+ MSNs compared with neighboring D2+ or D1− MSNs ([@R21]; [@R23]; [@R28]; [@R36]; [@R42]). We have previously shown that vHPC and BLA inputs are bidirectionally redistributed after cocaine exposure, with the strength of individual vHPC connections weakened, and the number of BLA connections increased at D1+ MSNs in the NAcMS ([@R36]). Here we extend on these findings by showing that drug-evoked changes critically depend on the specific long-range projection targets of D1+ MSNs. Our findings are parsimonious with previous observations but show how even more specific subnetworks of MSNs are affected by drug exposure. Given that drug-evoked plasticity evolves after withdrawal, with changes in AMPAR and NMDAR responses shifting over days and weeks ([@R29]; [@R33]; [@R42]; [@R51]), it will be important to assess synaptic changes in these subnetworks of MSNs at other time points after drug exposure and to determine how they contribute to drug-related behaviors.

Our results indicate that cocaine exposure shifts the influence of vHPC and BLA inputs on divergent NAc output to the VP and the VTA. We find that vHPC inputs are initially biased only onto D1+^VTA^ MSNs and that cocaine selectively reduces vHPC inputs only onto these cells. Interestingly, recent work shows that the primary target of NAcMS D1+ terminals in the VTA are medial dopamine neurons that project back to NAcMS ([@R53]). The selective dampening of vHPC inputs onto D1^+VTA^ MSNs might represent a disinhibitory mechanism, reducing the inhibition onto dopamine neurons in the VTA, and in turn enhancing dopamine release in the NAcMS. This could work in harmony with local disinhibition in the lateral VTA to drive cocaine-induced behaviors ([@R5]; [@R53]). In contrast, we found that BLA inputs are initially unbiased onto MSNs, but cocaine selectively enhanced BLA inputs only onto D1+^VP^ MSNs. Because cocaine sensitization is dependent on potentiation of D1+ MSN outputs to the VP ([@R13]), the plasticity we observe may reflect an upstream circuit mechanism to enhance D1+ terminal activity in the VP. Given the diversity of cell types and projections of the VP ([@R15]; [@R37]; [@R52]), in the future it will be important to determine the precise circuit connections of D1+ and D1− MSNs in this region.

Overall, our work highlights that circuitry and drug-evoked plasticity in the NAc are not simply regulated at levels of input (vHPC versus BLA), receptor expression (D1 versus D2), or projection target (VP versus VTA) but rather a complex combination of these factors. Importantly, many of these details would be missed when pooling vHPC and BLA inputs, D1+ and D1− cells, or even D1+^VTA^ and D1+^VP^ cells. Therefore, our results expand the classical binary view of D1+ and D2+ MSNs and highlight the heterogeneity of D1+ MSNs within the NAcMS. An exciting future direction will be to determine if projection identity distinguishes distinct subpopulations of MSNs in other parts of the striatum and if these neurons also undergo differential plasticity in disease states.

STAR★METHODS {#S7}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S8}
---------------------------------------

Further information and requests for resources and reagents should be directed and will be fulfilled by the Lead Contact, Adam Carter (<adam.carter@nyu.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S9}
--------------------------------------

Physiology experiments were performed in acute slices from D1-tdTomato hemizygous BAC transgenic mice ([@R1]) crossed with wild-type C57BL/6J mice (originally purchased from Jackson Laboratories). Behavior and anatomy experiments also used wild-type mice. For all experiments both sexes were used, and mice were aged P42-P70. No animals had been involved in previous procedures. Animals were group-housed with same-sex littermates in a dedicated animal care facility and were maintained on a 12-hour light / dark cycle with food and water given *ad libitum*. All procedures were conducted in accordance with guidelines approved by the New York University animal welfare committee.

METHOD DETAILS {#S10}
--------------

All experiments were replicated in at least 3 animals. For all cocaine experiments, pairs of sex-matched littermates were weaned and housed together. Within a given pair, one mouse was assigned to the cocaine group and the other to the saline group and both mice underwent all surgical, behavioral and recording procedures together to control for age, viral expression time and experimental conditions. Experimenters were not blind to experimental groups. No pre-test analyses were used to estimate sample sizes. No data were excluded from final analyses.

### Stereotaxic injections {#S11}

Stereotaxic injections were performed on P33-P46 mice. Mice were anesthetized with a mixture of ketamine (10 mg/ml) and xylazine (0.1 mg/ml) and head fixed in a stereotax (Kopf Instruments). A small craniotomy was made over the injection site, through which retrograde tracers and viruses were injected. Injection site coordinates were determined relative to bregma (mediolateral axis, dorsoventral axis, and rostrocaudal axis (in mm): NAc = −1.7, −4.4, +1.6 at a 14° angle; vHPC = −3.0, −4.6 and −3.6, −3.0; BLA = −3.1, −5.0, −1.5; VP = −1.4, −5.7, −2.5 at a 27° angle approaching from the caudal end of the skull; VTA= −0.4, −4.5, −3.0). Borosilicate pipettes with 5--10 μm tip diameters were backfilled and 100 -- 360 nL was pressure-injected using a Nanoject III (Drummond) with 45 -- 60 s inter-injection intervals. Pipettes were left in place for at least 10 minutes after injection before being slowly withdrawn. AAV1-hSyn-GFP (UPenn Vector Core, AV-1-PV1696) and AAV1-DIO-eYFP (UPenn Vector Core, AV-1-27056) were used for Cre-independent and -dependent axon labeling, and optogenetic stimulation was achieved with AAV1-hSyn-ChR2-eYFP (UPenn Vector Core, AV-1-26973P). For retrograde labeling, pipettes were filled with cholera toxin subunit B (CTB) conjugated to Alexa 488 or 647 (Life Technologies). After all injections, animals were returned to their home cages for 10 -- 16 days before being used for experiments.

### Slice preparation {#S12}

Mice were anesthetized with an intraperitoneal injection of a lethal dose of ketamine/xylazine and perfused intracardially with an ice-cold cutting solution containing the following (in mM): 65 sucrose, 76 NaCl, 25 NaHCO~3~,1.4 NaH~2~PO~4~, 25 glucose, 2.5 KCl, 7 MgCl~2~, 0.4 Na-ascorbate, and 2 Na-pyruvate (bubbled with 95% O~2~/5% CO~2~). 300 μm coronal sections were cut in this solution and transferred to ACSF containing the following (in mM): 120 NaCl, 25 NaHCO~3~,1.4 NaH~2~PO~4~, 21 glucose, 2.5 KCl, 2 CaCl~2~, 1 MgCl~2~, 0.4 Na-ascorbate, and 2 Na-pyruvate (bubbled with 95% O~2~/5% CO~2~). Slices recovered for 30 min at 35°C and then were stored for at least 30 min at 24°C prior to recording. All experiments were conducted at 30 -- 32°C.

### Electrophysiology {#S13}

Whole-cell recordings were made from fluorescently identified MSNs in the NAcMS, located 300 -- 600 μm medial to the anterior commissure. D1+ and D1− MSNs were identified by the presence or lack of tdTomato fluorescence ([@R46]). D1+^VTA^ and D1+^VP^ projection neurons were identified by the additional expression of CTB-647. Neurons were recorded in sequential pairs (D1+ x D1−, D1+^VTA^ x D1−, or D1+^VP^ x D1−), where cells were located at the same depth in the slice and within 50 μm of each other ([@R35], [@R36]; [@R46]). Recording order was varied between cell types within a given pair. For voltage-clamp experiments, borosilicate pipettes (3-5 MΩ) were filled with a Cs-based internal (in mM: 130 Cs-gluconate, 10 HEPES, 10 Na-phosphocreatine, 4 Mg~2~-ATP, 0.4 NaGTP, 10 TEA, 2 QX-314, and 10 EGTA, pH 7.3 with CsOH). For current-clamp recordings, pipettes were filled with a K-based internal (in mM: 135 K-gluconate, 7 KCl, 10 HEPES, 10 Na-phosphocreatine, 4 Mg~2~-ATP, 0.3 NaGTP, and 0.5 EGTA, pH 7.3 with KOH) with 30 μM AlexaFluor-594 added to visualize morphology with 2-photon microscopy. All voltage-clamp recordings were made with 10 μM gabazine to block GABA~A~ receptors and with 10 μM D-serine to allow NMDAR activation. Cells were held at −70 mV to measure AMPAR-mediated currents, and at +40 mV from the experimentally-determined excitatory reversal potential to measure NMDAR-mediated currents. Current-clamp recordings were made with 10 μM NBQX to block AMPAR, 10 μM CPP to block NMDAR, and 10 μM gabazine, and current steps were applied to cells from a holding potential set to −80 mV. Input resistance was calculated using a −50 pA current injection. All chemicals were purchased from Tocris Bioscience or Sigma.

Electrophysiological data were collected using a MultiClamp 700B (Axon Instruments), signals were sampled at 10 kHz, and filtered at 2 kHz for voltage-clamp and 10 kHz for current-clamp recordings. Series resistance was monitored, less than 25 MΩ, and not compensated.

### Optogenetics {#S14}

Glutamate release was triggered by activating channelrhodopsin-2 (ChR2) present in presynaptic terminals of vHPC or BLA inputs to the NAc using 1 -- 2 ms pulses (unless otherwise indicated) of 473 nm light from a blue light-emitting diode (LED; 473 nm; Thorlabs) through a 10X0.3 NA immersion objective (Olympus) with a power range of 2 -- 22 mW measured at the back focal plane of the objective. Within a given pair of neurons, a light intensity was empirically chosen that yielded usable responses (i.e., 50 -- 1000 pA EPSC amplitude at −70 mV for voltage-clamp experiments).

### Two-photon microscopy {#S15}

To obtain images of recorded neurons, cells were filled via the patch pipette during whole-cell recording with AlexaFluor-594 dye (30 μM in internal solution) for at least 15 minutes. Two-photon imaging was performed on a custom microscope using a Titanium:Sapphire laser (Coherent) tuned to 810 nm ([@R10]; [@R11]). Az-stack was acquired at 512 × 512 resolution through a 60X 1.0NA objective (Olympus). Morphological reconstruction and analysis of two-photon images were conducted using Volume Integration and Alignment System (Vias) and Neuron Studio software (Computational Neurobiology and Imaging Center, Mount Sinai School of Medicine).

### Histology and fluorescence microscopy {#S16}

Mice were anesthetized and perfused intracardially with 0.01 M PBS followed by 4% PFA. Brains were stored in 4% PFA for 12 -- 18 hours at 4°C before being washed three times in 0.01 M PBS. Slices were cut on a VT-1000S vibratome (Leica) at 70 μm thickness, or 40 μm for immunostaining, and were either mounted directly onto gel-coated glass slides or processed for immunolabeling. For tdTomato immunolabeling, slices were incubated for 1 hour in blocking solution (1% bovine serum albumin and 0.2% Triton-X in 0.01 M PBS), primary antibody was applied overnight (rabbit anti-RFP (Rockland) at 1:1000 in blocking solution). Slices were then washed in PBS and incubated with secondary antibody (goat anti-rabbit 594 (abcam) at 1:400), in blocking solution) for 1.5 hours. Slices were coverslipped using ProLong Gold anti-fade reagent with DAPI (Invitrogen) or VectaShield with DAPI (Vector Labs). Fluorescent images were taken on an Olympus VS120 microscope, using a 10X 0.25NA objective (Olympus) or a Leica TCS SP8 confocal microscope, using a 20X 0.75NA and 40X 1.3NA objective (Olympus). All images were processed using NIH ImageJ.

### Cocaine sensitization {#S17}

Mice were first habituated to the behavior room for one 2-hour session. The next day, they were placed in a dimly-lit, sound-attenuated behavioral chamber (1 ft x 1 ft) for a 35-min habituation session. On the following day, to acclimate the animals to injections and to obtain a baseline locomotion measure, mice were placed in the chamber for a 15-min baseline period followed by an IP injection of saline and a 20-min post-injection session in the chamber. Animals then underwent 5 days (1 session per day) of cocaine (15 mg/kg) or saline injection sessions in the chamber. Subsequently, animals either underwent a cocaine challenge session, where both cocaine-treated and saline-treated mice received a 15 mg/kg IP injection of cocaine or were anesthetized and perfused for preparation of acute slices. Behavior was recorded via an overhead camera linked to Ethovision software (Noldus), which quantified locomotor activity during each session. Locomotor sensitization data presented were acquired from pairs of animals used only for behavior, and represent distance traveled (m) during the 20-minute post-injection session. For electrophysiology experiments, D1-tdTomato mice were injected with optogenetic constructs and given at least 10 days to recover prior to initiating behavioral sessions, as described above.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S18}
---------------------------------------

Electrophysiology and two-photon imaging data were acquired using custom software in MATLAB (MathWorks). All electrophysiology, anatomical, and behavioral data were collected from a minimum of 3 animals from different litters. Electrophysiology data analysis was performed in Igor Pro (Wavemetrics). EPSC amplitudes were averaged from a 1 ms window around the peak current for AMPAR EPSCs, and 50 ms after stimulation for NMDAR EPSCs. Average traces in figures depict mean ± SEM of all recorded pairs. Statistical significance of differences between two groups was evaluated using the Wilcoxon Signed-Rank test for paired data or the Mann-Whitney test for unpaired data, and with repeated-measure 2-way ANOVA followed by Sidak's multiple comparison test for drug effects with p values \<0.05 considered significant. Image analysis was conducted using NIH ImageJ. Statistical tests and graph generation were performed using Prism 7 (GraphPad).
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![D1+ MSNs Projecting to VP and VTA Are Distinct Cell Populations\
(A) Left: schematic and representative images for injections of CTB-647 into the VP (green) and CTB-488 into the VTA (blue) of D1-tdTomato mice (red) (scale bar, 500 μm). Right: confocal images of retrogradely labeled neurons in the NAcMS (arrows indicate dual-labeled MSNs; scale bar, 100 μm).\
(B) Left: quantification of CTB and tdTomato overlap in the NAcMS (total cell count of three slices per mouse, five mice). Right: summary of the number of D1+^VTA^, D1+^VP^ and dual-projecting MSNs in the NAcMS (average number of labeled cells of three slices per mouse, five mice).\
(C) Two-photon images of D1+^VTA^, D1+^VP^, and D1− MSNs (left) (scale bar, 20 μm) and quantification of total dendritic length for all reconstructed cells (right), showing no differences.\
(D) Examples of physiological responses of D1+^VTA^, D1+^VP^, and D1− MSNs to current injections of 250 and −50 pA. Right: summary of current step-evoked firing, showing similar number of action potentials (APs) for D1+^VTA^ and D1+^VP^ MSNs.\
Box-and-whisker plots represent median and minimum to maximum. F-I curve is presented as mean ± SEM. \*p \< 0.05.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1538464-f0001){#F1}

![vHPC Inputs Are Stronger onto D1+^VTA^ Cells in Naive Mice\
(A) Left: schematic for injections of AAV-ChR2-eYFP into the vHPC and CTB-647 into the VP or the VTA. Right: representative image of viral expression in the vHPC (scale bar, 500 μm) and of dense vHPC axon labeling in the NAcMS (scale bar, 100 μm).\
(B) Left: vHPC inputs evoke larger EPSCs at D1+^VTA^ MSNs compared with neighboring D1− MSNs. Middle: summary of the absolute amplitude of vHPC-evoked AMPAR EPSCs at D1− and D1+^VTA^ MSNs, where lines indicate pairs of recorded neurons. Right: summary of D1+^VTA^/D1− amplitude ratios for AMPAR EPSCs at −70 mV and NMDAR EPSCs at +40 mV.\
(C) Similar to (B), showing no bias of vHPC inputs onto pairs of D1+^VP^ and D1− MSNs.\
(D) Left: schematic for injections of AAV-ChR2-eYFP into the BLA and CTB-647 into the VP or the VTA. Right: representative image of viral expression in the BLA (scale bar, 500 μm) and of BLA axon labeling in the NAcMS (scale bar, 100 μm).\
(E) Left: there is no bias of BLA-evoked EPSCs at D1+^VTA^ MSNs compared to neighboring D1− MSNs. Middle: summary of the absolute amplitude of BLA-evoked AMPAR EPSCs at D1− and D1+^VTA^ MSNs, where lines indicate pairs of recorded neurons. Right: summary of D1+^VTA^/D1− amplitude ratios for AMPAR EPSCs at −70 mV and NMDAR EPSCs at +40 mV.\
(F) Similar to (E) showing no bias of BLA-evoked EPSCs at D1+^VP^ MSNs compared to neighboring D1− MSNs.\
Average traces are presented as mean ± SEM. Ratio data are presented as geometric mean with 95% CI on logarithmic axes. \*p \< 0.05.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1538464-f0002){#F2}

![Cocaine-Induced Plasticity Depends on Projection Target\
(A) Sensitization protocol, with 3 days of habituation, 5 days of either cocaine or saline injections, and 1 day of withdrawal, followed by either cocaine challenge to assess behavior or slice recordings to study synaptic physiology.\
(B) Left: typical movement of saline and cocaine mice to a challenge dose of cocaine on day 6 of the protocol. Middle: summary of distance traveled in the cocaine challenge session. Right: summary of distance traveled per experiment day.\
(C) Left: vHPC inputs evoke larger EPSCs at D1+^VTA^ MSNs in saline mice, but this bias is abolished in cocaine mice. Right: summary of D1+^VTA^/D1− amplitude ratios.\
(D) Similar to (C), showing equivalent vHPC-evoked EPSCs at D1+^VP^ and D1− MSNs in both saline and cocaine mice.\
(E) Left: BLA-evoked EPSCs are similar at D1+^VTA^ and D1− MSNs in saline and cocaine mice. Right: summary of D1+^VTA^/D1− amplitude ratios.\
(F) Similar to (E) but showing a large increase in EPSCs at D1+^VP^ MSNs in cocaine mice.\
Average traces are presented as mean ± SEM. Ratio data are presented as geometric mean with 95% CI on logarithmic axes. \*p \< 0.05.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1538464-f0003){#F3}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                              SOURCE                                    IDENTIFIER
  ------------------------------------------------ ----------------------------------------- ---------------------------------------------
  Antibodies                                                                                 
  Rabbit Anti-RFP                                  Rockland Antibodies and Assays            Rockland Cat\# 600-401-379; RRID:AB_2209751
  Goat Anti-Rabbit 594                             Abcam                                     Abcam Cat\# ab150080; RRID:AB_2650602
  Bacterial and Virus Strains                                                                
  AAV1-hSYn-hChR2-eYFP                             Penn Vector Core                          AV-1-26973P
  AAV1 -hSYn-eYFP                                  Penn Vector Core                          AV-1-PV1696
  AAV1-EF1a-DIO-eYFP                               Penn Vector Core                          AV-1-27056
  Chemicals, Peptides, and Recombinant Proteins                                              
  Cholera toxin subunit B-488                      Thermo Fisher                             Cat\# C22841
  Cholera toxin subunit B-647                      Thermo Fisher                             Cat\# C34778
  Gabazine                                         Tocris                                    Cat\# 1262
  D-Serine                                         Tocris                                    Cat\# 0226
  Prolong Gold with DAPI                           Invitrogen                                Cat\# P36931
  VectaShield with DAPI                            Vector Labs                               RRID: AB_2336790
  Cocaine Hydrochloride                            Sigma-Aldrich                             Cat\# C5776
  Experimental Models: Organisms/Strains                                                     
  Mouse: C57BL/6J                                  Jackson Lab                               RRID: IMSR_JAX:000664
  Mouse: D1-tdTomato                               Jackson Lab                               RRID:IMSR_JAX:016204
  Mouse: D1-Cre                                    Jackson Lab                               RRID:MMRRC_030989-UCD
  Software and Algorithms                                                                    
  Igor Pro 6                                       WaveMetrics                               RRID: SCR_000325
  MATLAB                                           MathWorks                                 RRID: SCR_001622
  Prism 7.0                                        GraphPad Software                         RRID: SCR_002798
  Volume Integration and Alignment System (VIAS)   Icahn School of Medicine at Mount Sinai   RRID:SCR_013800
  Neuron Studio Software                           Icahn School of Medicine at Mount Sinai   RRID:SCR 013798

###### Highlights

-   NAc medial shell has multiple D1 receptor-expressing (D1+) medium spiny neurons (MSNs)

-   Distinct D1+ MSNs project to ventral tegmental area (VTA) and ventral pallidum (VP)

-   Hippocampus (vHPC) and amygdala (BLA) differentially target D1+^VTA^ and D1+^VP^ MSNs

-   Cocaine selectively alters vHPC inputs at D1+^VTA^ MSNs and BLA inputs at D1+^VP^ MSNs
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